Search

Your search keyword '"von Wachenfeldt, Anna"' showing total 154 results

Search Constraints

Start Over You searched for: Author "von Wachenfeldt, Anna" Remove constraint Author: "von Wachenfeldt, Anna"
154 results on '"von Wachenfeldt, Anna"'

Search Results

2. BRCA1 frameshift variants leading to extended incorrect protein C termini

4. Interplay between BRCA1 and RHAMM Regulates Epithelial Apicobasal Polarization and May Influence Risk of Breast Cancer

5. BRCA1 frameshift variants leading to extended incorrect protein C-termini

6. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

7. BRCA1 frameshift variants leading to extended incorrect protein C termini

8. Side effects and its management in adjuvant endocrine therapy for breast cancer : a matter of communication and counseling

9. Adherence to adjuvant endocrine therapy after breast cancer in Sweden - a nationwide cohort study in 1-, 3- and 5-year survivors with a focus on regional differences.

10. Supplementary Table 2 from Candidate Genetic Modifiers for Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

11. Supplementary Tables 1-4 from Common Variants at the 19p13.1 and ZNF365 Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

12. Supplementary Table 3 from Candidate Genetic Modifiers for Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

13. Data from Common Variants at the 19p13.1 and ZNF365 Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

16. Assessment of early response biomarkers in relation to long‐term survival in patients with HER2‐negative breast cancer receiving neoadjuvant chemotherapy plus bevacizumab: Results from the Phase II PROMIX trial

17. «VI ER SOM EN POSE TWIST – VELDIG GODE, MEN FORSKJELLIGE!» En narrativ analyse av fellesskapets betydning for karriereutvikling

18. A hypothesis-generating search for new genetic breast cancer syndromes - a national study in 803 Swedish families

20. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

21. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

22. Tumour spectrum in non-BRCA hereditary breast cancer families in Sweden

23. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

24. Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

25. An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers

26. Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores

27. Biverkningar vid antihormonell behandling påverkar följsamhet : Viktigt vara medveten om problemen för att motivera patienter att fullfölja behandlingen

28. Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers

29. Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170

30. Abstract P2-05-02: Preliminary translational results from PROMIX, a phase II trial of preoperative chemotherapy with the addition of bevacizumab in large operable and locally advanced HER2-negative breast cancer

31. Common Variants at the 19p13.1 and ZNF365 Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

32. Breast cancer risk and 6q22.33 : combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2

33. Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers

34. Interplay between BRCA1 and RHAMM Regulates Epithelial Apicobasal Polarization and May Influence Risk of Breast Cancer

35. Common breast cancer susceptibility alleles are associated with tumor subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2

36. A hypothesis-generating search for new genetic breast cancer syndromes : a national study in 803 Swedish families

37. Common Variants at the 19p13.1 and ZNF365 Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

40. Psychological Reactions, Quality of Life, and Body Image After Bilateral Prophylactic Mastectomy in Women At High Risk for Breast Cancer: A Prospective 1-Year Follow-Up Study

43. Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170

44. Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

45. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

46. Common Variants at the 19p13.1 and ZNF365 Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

47. Assessment of early response biomarkers in relation to long-term survival in patients with HER2-negative breast cancer receiving neoadjuvant chemotherapy plus bevacizumab: Results from the Phase II PROMIX trial

48. Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

49. Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

50. Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170

Catalog

Books, media, physical & digital resources